Agency Forms Undergoing Paperwork Reduction Act Review, 35868-35870 [E9-17263]
Download as PDF
<![CDATA[
35868
Federal Register / Vol. 74, No. 138 / Tuesday, July 21, 2009 / Notices
viruses. For additional information
about EPA’s public docket visit the EPA
Docket Center homepage at https://
www.epa.gov/epahome/dockets.htm.
Docket: All documents in the docket
are listed in the https://
www.regulations.gov index. Although
listed in the index, some information is
not publicly available, e.g., CBI or other
information whose disclosure is
restricted by statute. Certain other
material, such as copyrighted material,
will be publicly available only in hard
copy. Publicly available docket
materials are available either
electronically in https://
www.regulations.gov or in hard copy at
the Board of Scientific Counselors
(BOSC), Executive Committee
Meeting—August 6, 2009 Docket, EPA/
DC, EPA West, Room B102, 1301
Constitution Ave., NW., Washington,
DC. The Public Reading Room is open
from 8:30 a.m. to 4:30 p.m., Monday
through Friday, excluding legal
holidays. The telephone number for the
Public Reading Room is (202) 566–1744,
and the telephone number for the ORD
Docket is (202) 566–1752.
FOR FURTHER INFORMATION CONTACT: The
Designated Federal Officer via mail at:
Lorelei Kowalski, Mail Code 8104–R,
Office of Science Policy, Office of
Research and Development,
Environmental Protection Agency, 1200
Pennsylvania Avenue, NW.,
Washington, DC 20460; via phone/voice
mail at: (202) 564–3408; via fax at: (202)
565–2911; or via e-mail at:
kowalski.lorelei@epa.gov.
jlentini on DSKJ8SOYB1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
General Information
Any member of the public interested
in receiving a draft BOSC agenda or
making a presentation at this meeting
may contact Lorelei Kowalski, the
Designated Federal Officer, via any of
the contact methods listed in the ‘‘FOR
FURTHER INFORMATION CONTACT’’ section
above. In general, each individual
making an oral presentation will be
limited to a total of three minutes.
Proposed agenda items for the
teleconference include, but are not
limited to: vet the draft Human Health
program review report and discuss a
revised process for program reviews.
The meeting is open to the public.
Information on Services for
Individuals with Disabilities: For
information on access or services for
individuals with disabilities, please
contact Lorelei Kowalski at (202) 564–
3408 or kowalski.lorelei@epa.gov. To
request accommodation of a disability,
please contact Lorelei Kowalski,
preferably at least ten days prior to the
VerDate Nov<24>2008
16:50 Jul 20, 2009
Jkt 217001
meeting, to give EPA as much time as
possible to process your request.
Dated: July 14, 2009.
Mimi Dannel,
Acting Director, Office of Science Policy.
[FR Doc. E9–17276 Filed 7–20–09; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[FRL–8933–1]
Protection of Stratospheric Ozone:
Extension to Deadline for Critical Use
Exemption Applications for 2012
AGENCY: Environmental Protection
Agency (EPA).
ACTION: Extension to Submittal Date for
Applications. On May 20, 2009, the
Agency published a notice requesting
applications for the Critical Use
Exemption from the phaseout of methyl
bromide for 2012 (see 74 FR 23705).
On July 1, 2009, EPA received a letter
from methyl bromide stakeholders
requesting an extension to the July 20,
2009 deadline for submitting Critical
Use Exemption applications. The letter
requested a deadline of August 24, 2009.
The letter explained that additional
time is needed by the stakeholders to
complete their Critical Use Exemption
applications, citing recent industry
involvement with associated
international meetings and national
regulatory decisions as impeding their
ability to devote adequate time to the
application process.
EPA believes that the requested
extension is reasonable, and is granting
the extension to all applicants. Critical
Use Exemption Applications for 2012
are now due to the Agency on or before
August 24, 2009. A copy of the July 1,
2009 letter to the Agency is available in
the EPA Docket.
DATES: Applications for the 2012
Critical Use Exemption must be
postmarked on or before August 24,
2009.
ADDRESSES: Applications for the methyl
bromide Critical Use Exemption should
be submitted in duplicate (two copies)
by mail to: U.S. Environmental
Protection Agency, Office of Air and
Radiation, Stratospheric Protection
Division, Attention Methyl Bromide
Team, Mail Code 6205J, 1200
Pennsylvania Ave, NW., Washington,
DC 20460 or by courier delivery (other
than U.S. Post Office overnight) to: U.S.
Environmental Protection Agency,
Office of Air and Radiation,
Stratospheric Protection Division,
Attention Methyl Bromide Review
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Team, 1310 L St. NW., Room 1040,
Washington DC 20005. EPA also
encourages users to submit their
applications electronically to Robert
Burchard, Stratospheric Protection
Division, at: burchard.robert@epa.gov. If
the application is submitted
electronically, applicants must fax a
signed copy of Worksheet 1 to Robert
Burchard at 202–343–2338 by the
application deadline.
FOR FURTHER INFORMATION
CONTACT:
General Information: U.S. EPA
Stratospheric Ozone Information
Hotline, 1–800–296–1996; also https://
www.epa.gov/ozone/mbr.
Technical Information: Bill Chism,
U.S. Environmental Protection Agency,
Office of Pesticide Programs (7503P),
1200 Pennsylvania Ave., NW.,
Washington, DC 20460, 703–308–8136.
E-mail: chism.bill@epa.gov.
Economic Information: Elisa Rim,
U.S. Environmental Protection Agency,
Office of Pesticide Programs (7503P),
1200 Pennsylvania Ave., NW.,
Washington, DC 20460, 703–308–8123.
E-mail: rim.elisa@epa.gov.
Regulatory Information: Robert
Burchard, U.S. Environmental
Protection Agency, Stratospheric
Protection Division (6205J), 1200
Pennsylvania Ave., NW., Washington,
DC 20460, 202–343–9126. E-mail:
burchard.robert@epa.gov.
EPA Docket: The docket can be
accessed at the https://
www.regulations.gov site. To obtain
copies of materials in hard copy, please
e-mail the EPA Docket Center: a-and-rdocket@epa.gov. The Docket ID No. for
Critical Use Exemption Applications for
2012 is: EPA–HQ–OAR–2009–0277.
Dated: July 15, 2009.
Brian J. McLean,
Director, Office of Atmospheric Programs.
[FR Doc. E9–17275 Filed 7–20–09; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-09–0666]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
E:\FR\FM\21JYN1.SGM
21JYN1
35869
Federal Register / Vol. 74, No. 138 / Tuesday, July 21, 2009 / Notices
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
National Healthcare Safety Network
(NHSN) (OMB No. 0920–0666)—
Revision—National Center for
Preparedness, Detection, and Control of
Infectious Diseases (NCPDCID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The National Healthcare Safety
Network (NHSN) is a system designed to
accumulate, exchange, and integrate
relevant information and resources
among private and public stakeholders
to support local and national efforts to
protect patients and to promote
healthcare safety. Specifically, the data
is used to determine the magnitude of
various healthcare-associated adverse
events and trends in the rates of these
events among patients and healthcare
workers with similar risks. The data will
be used to detect changes in the
epidemiology of adverse events
resulting from new and current medical
therapies and changing risks.
Healthcare institutions that
participate in NHSN voluntarily report
their data to CDC using a web browser-
4,500 burden hours). These forms are no
longer needed by the NHSN. These
deletions total 4,800 burden hours.
NHSN was first approved by OMB in
2005 and a revision request was
approved by OMB in 2008. The 2008
revision request included modifications
to approved forms, new modules, and
an increase in the number of
respondents. Later in 2008, CDC
requested and received OMB approval
to increase the number of respondents
for the NHSN to 6,000 healthcare
facilities. This change was a result of an
increasing number of State legislatures
requiring reporting of healthcareacquired infections by healthcare
facilities using the NHSN.
Participating institutions must have a
computer capable of supporting an
Internet service provider (ISP) and
access to an ISP. The only other cost to
respondents is their time to complete
the appropriate forms.
OMB No. 0920–0666: National
Healthcare Safety Network (NHSN) is
currently approved for 5,144,844
annualized burden hours. This request
includes a net increase of 27,400 burden
hours (deletion of 2 forms: ¥4,800
burden hours; new Hemovigilance
Module: +32,200 burden hours),
bringing the total estimated annualized
burden hours for the entire information
collection request to 5,172,244 hours.
There are no additional respondents for
this request as they are already part of
the respondent population.
based technology for data entry and data
management. Data are collected by
trained surveillance personnel using
written standardized protocols. This
revision submission to OMB is a request
to add a Hemovigilance module to the
NHSN. This module is a response to a
recommendation from HHS’ Advisory
Committee on Blood Safety and
Availability (ACBSA) to develop a
national system for outcome
surveillance that includes recipients of
blood and blood products. The module
consists of 6 additional forms: (1) The
Hemovigilance Module Annual Survey
(1,000 annualized burden hours); (2) the
Hemovigilance Module Monthly
Reporting Plan (200 annualized burden
hours); (3) Hemovigilance Module
Blood Produce Incident Reporting—
Summary Data (12,000 annualized
burden hours); (4) Hemovigilance
Module Monthly Reporting
Denominators (3,000 annualized burden
hours); (5) Hemovigilance Incident form
(6,000 annualized burden hours); and
(6) Hemovigilance Adverse Reaction
form (10,000 annualized burden hours).
The Hemovigilance Module totals an
estimated 32,200 annualized burden
hours
Also in this submission, CDC is also
requesting to delete two forms currently
approved by OMB: Implementation of
Engineering Controls (currently
approved for 300 burden hours) and the
Laboratory Identified Multi-drug
Resistant Organism (MDRO) Event
Summary Form (currently approved for
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Form
Infection Control Practitioner ..........................
Facility Contact Information ...........................
Patient Safety Component Hospital Survey ..
Agreement to Participate and Consent ..........
Group Contact Information .............................
Patient Safety Monthly Reporting Plan ..........
Healthcare Personnel Safety Reporting Plan
Primary Bloodstream Infection (BSI) .............
Pneumonia (PNEU)—also includes Any Patient Pneumonia Flow Diagram and Infant
and Children Pneumonia Flow Diagram.
Urinary Tract Infection (UTI) ..........................
Surgical Site Infection (SSI) ...........................
Dialysis Event (DI) .........................................
Antimicrobial Use and Resistance (AUR)—
Microbiology Laboratory Data.
Antimicrobial Use and Resistance—Pharmacy Data.
Denominators for Intensive Care Unit (ICU)/
Other locations (Not NICU or SCA).
Denominators for Specialty Care Area (SCA)
Denominators for Neonatal Intensive Care
Unit (NICU).
Denominator for Procedure ............................
Denominator for Outpatient Dialysis ..............
Dialysis Survey ...............................................
jlentini on DSKJ8SOYB1PROD with NOTICES
.
VerDate Nov<24>2008
16:50 Jul 20, 2009
Jkt 217001
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
E:\FR\FM\21JYN1.SGM
Number of
responses per
respondent
Average
burden per
response (in
hours)
6,000
6,000
6,000
6,000
6,000
600
6,000
6,000
1
1
1
1
9
9
36
72
10/60
30/60
15/60
5/60
35/60
10/60
30/60
30/60
6,000
6,000
225
6,000
27
27
200
45
30/60
30/60
15/60
3
6,000
36
2
6,000
18
5
6,000
6,000
9
9
5
4
6,000
225
225
540
9
1
8/60
5/60
1
21JYN1
35870
Federal Register / Vol. 74, No. 138 / Tuesday, July 21, 2009 / Notices
ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued
Respondents
Number of
respondents
Form
List of Blood Isolates ......................................
Manual Categorization of Positive Blood Cultures.
Exposures to Blood/Body Fluids ....................
Healthcare Personnel Post-exposure Prophylaxis.
Healthcare Personnel Demographic Data .....
Healthcare Personnel Vaccination History ....
Annual Facility Survey ...................................
Healthcare Worker Survey .............................
Healthcare Personnel Influenza Vaccination
Form.
Healthcare Personnel Influenza Antiviral
Medication Administration Form.
Pre-season Survey on Influenza Vaccination
Programs for Healthcare Workers.
Post-Season Survey on Influenza Vaccination Programs for Healthcare Workers.
Central Line Insertion Practices Adherence
Monitoring Form (CLIP).
Laboratory Testing .........................................
MDRO Prevention Process and Outcome
Measures Monthly Monitoring Form.
MDRO or CDAD Infection Event Form ..........
Laboratory Identified MDRO or CDAD Event
Form (LabID).
Registration Form ...........................................
High Risk Inpatient Influenza Vaccine—Summary Form Method A.
High Risk Inpatient Influenza Vaccine—Numerator Data Form Method B.
High Risk Inpatient Influenza Vaccine—Summary Form Method B.
High Risk Inpatient Influenza Vaccine—Denominator Data Form Method B.
Hemovigilance Module Annual Survey ..........
Hemovigilance Module Monthly Reporting
Plan.
Hemovigilance Module Blood Product Incident Reporting—Summary Data.
Hemovigilance Module Monthly Reporting
Denominators.
Hemovigilance Incident ..................................
Hemovigilance Adverse Reaction ..................
Dated: July 13, 2009.
Marilyn S. Radke,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. E9–17263 Filed 7–20–09; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
[60 Day–09–09CD]
Centers for Disease Control and
Prevention
jlentini on DSKJ8SOYB1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects.
Alternatively, to obtain a copy of the
VerDate Nov<24>2008
16:50 Jul 20, 2009
Jkt 217001
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response (in
hours)
6,000
6,000
1
1
1
1
600
600
50
10
1
15/60
600
600
600
600
600
200
300
1
100
500
20/60
10/60
8
10/60
10/60
600
50
10/60
600
1
10/60
600
1
10/60
6,000
100
10/60
600
6,000
100
24
15/60
10/60
6,000
6,000
72
240
30/60
30/60
6,000
6,000
1
5
5/60
16
2,000
250
10/60
2,000
5
4
2,000
250
5/60
500
500
1
12
2
2/60
500
12
2
500
12
30/60
500
500
72
120
10/60
10/60
data collection plans and instrument,
call 404–639–5960 and send comments
to Maryam I. Daneshvar, CDC Reports
Clearance Officer, 1600 Clifton Road,
NE., MS–D74, Atlanta, Georgia 30333;
comments may also be sent by e-mail to
omb@cdc.gov.
Comments are invited on (a) whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have a
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
E:\FR\FM\21JYN1.SGM
21JYN1
]]>Agencies
[Federal Register Volume 74, Number 138 (Tuesday, July 21, 2009)]
[Notices]
[Pages 35868-35870]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-17263]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-09-0666]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these
[[Page 35869]]
requests, call the CDC Reports Clearance Officer at (404) 639-5960 or
send an e-mail to omb@cdc.gov. Send written comments to CDC Desk
Officer, Office of Management and Budget, Washington, DC or by fax to
(202) 395-6974. Written comments should be received within 30 days of
this notice.
Proposed Project
National Healthcare Safety Network (NHSN) (OMB No. 0920-0666)--
Revision--National Center for Preparedness, Detection, and Control of
Infectious Diseases (NCPDCID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The National Healthcare Safety Network (NHSN) is a system designed
to accumulate, exchange, and integrate relevant information and
resources among private and public stakeholders to support local and
national efforts to protect patients and to promote healthcare safety.
Specifically, the data is used to determine the magnitude of various
healthcare-associated adverse events and trends in the rates of these
events among patients and healthcare workers with similar risks. The
data will be used to detect changes in the epidemiology of adverse
events resulting from new and current medical therapies and changing
risks.
Healthcare institutions that participate in NHSN voluntarily report
their data to CDC using a web browser-based technology for data entry
and data management. Data are collected by trained surveillance
personnel using written standardized protocols. This revision
submission to OMB is a request to add a Hemovigilance module to the
NHSN. This module is a response to a recommendation from HHS' Advisory
Committee on Blood Safety and Availability (ACBSA) to develop a
national system for outcome surveillance that includes recipients of
blood and blood products. The module consists of 6 additional forms:
(1) The Hemovigilance Module Annual Survey (1,000 annualized burden
hours); (2) the Hemovigilance Module Monthly Reporting Plan (200
annualized burden hours); (3) Hemovigilance Module Blood Produce
Incident Reporting--Summary Data (12,000 annualized burden hours); (4)
Hemovigilance Module Monthly Reporting Denominators (3,000 annualized
burden hours); (5) Hemovigilance Incident form (6,000 annualized burden
hours); and (6) Hemovigilance Adverse Reaction form (10,000 annualized
burden hours). The Hemovigilance Module totals an estimated 32,200
annualized burden hours
Also in this submission, CDC is also requesting to delete two forms
currently approved by OMB: Implementation of Engineering Controls
(currently approved for 300 burden hours) and the Laboratory Identified
Multi-drug Resistant Organism (MDRO) Event Summary Form (currently
approved for 4,500 burden hours). These forms are no longer needed by
the NHSN. These deletions total 4,800 burden hours.
NHSN was first approved by OMB in 2005 and a revision request was
approved by OMB in 2008. The 2008 revision request included
modifications to approved forms, new modules, and an increase in the
number of respondents. Later in 2008, CDC requested and received OMB
approval to increase the number of respondents for the NHSN to 6,000
healthcare facilities. This change was a result of an increasing number
of State legislatures requiring reporting of healthcare-acquired
infections by healthcare facilities using the NHSN.
Participating institutions must have a computer capable of
supporting an Internet service provider (ISP) and access to an ISP. The
only other cost to respondents is their time to complete the
appropriate forms.
OMB No. 0920-0666: National Healthcare Safety Network (NHSN) is
currently approved for 5,144,844 annualized burden hours. This request
includes a net increase of 27,400 burden hours (deletion of 2 forms: -
4,800 burden hours; new Hemovigilance Module: +32,200 burden hours),
bringing the total estimated annualized burden hours for the entire
information collection request to 5,172,244 hours. There are no
additional respondents for this request as they are already part of the
respondent population.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Respondents Form respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Infection Control Practitioner........ Facility Contact 6,000 1 10/60
Information.
Patient Safety Component 6,000 1 30/60
Hospital Survey.
Agreement to Participate 6,000 1 15/60
and Consent.
Group Contact 6,000 1 5/60
Information.
Patient Safety Monthly 6,000 9 35/60
Reporting Plan.
Healthcare Personnel 600 9 10/60
Safety Reporting Plan.
Primary Bloodstream 6,000 36 30/60
Infection (BSI).
Pneumonia (PNEU)--also 6,000 72 30/60
includes Any Patient
Pneumonia Flow Diagram
and Infant and Children
Pneumonia Flow Diagram.
Urinary Tract Infection 6,000 27 30/60
(UTI).
Surgical Site Infection 6,000 27 30/60
(SSI).
. Dialysis Event (DI)..... 225 200 15/60
Antimicrobial Use and 6,000 45 3
Resistance (AUR)--
Microbiology Laboratory
Data.
Antimicrobial Use and 6,000 36 2
Resistance--Pharmacy
Data.
Denominators for 6,000 18 5
Intensive Care Unit
(ICU)/Other locations
(Not NICU or SCA).
Denominators for 6,000 9 5
Specialty Care Area
(SCA).
Denominators for 6,000 9 4
Neonatal Intensive Care
Unit (NICU).
Denominator for 6,000 540 8/60
Procedure.
Denominator for 225 9 5/60
Outpatient Dialysis.
Dialysis Survey......... 225 1 1
[[Page 35870]]
List of Blood Isolates.. 6,000 1 1
Manual Categorization of 6,000 1 1
Positive Blood Cultures.
Exposures to Blood/Body 600 50 1
Fluids.
Healthcare Personnel 600 10 15/60
Post-exposure
Prophylaxis.
Healthcare Personnel 600 200 20/60
Demographic Data.
Healthcare Personnel 600 300 10/60
Vaccination History.
Annual Facility Survey.. 600 1 8
Healthcare Worker Survey 600 100 10/60
Healthcare Personnel 600 500 10/60
Influenza Vaccination
Form.
Healthcare Personnel 600 50 10/60
Influenza Antiviral
Medication
Administration Form.
Pre-season Survey on 600 1 10/60
Influenza Vaccination
Programs for Healthcare
Workers.
Post-Season Survey on 600 1 10/60
Influenza Vaccination
Programs for Healthcare
Workers.
Central Line Insertion 6,000 100 10/60
Practices Adherence
Monitoring Form (CLIP).
Laboratory Testing...... 600 100 15/60
MDRO Prevention Process 6,000 24 10/60
and Outcome Measures
Monthly Monitoring Form.
MDRO or CDAD Infection 6,000 72 30/60
Event Form.
Laboratory Identified 6,000 240 30/60
MDRO or CDAD Event Form
(LabID).
Registration Form....... 6,000 1 5/60
High Risk Inpatient 6,000 5 16
Influenza Vaccine--
Summary Form Method A.
High Risk Inpatient 2,000 250 10/60
Influenza Vaccine--
Numerator Data Form
Method B.
High Risk Inpatient 2,000 5 4
Influenza Vaccine--
Summary Form Method B.
High Risk Inpatient 2,000 250 5/60
Influenza Vaccine--
Denominator Data Form
Method B.
Hemovigilance Module 500 1 2
Annual Survey.
Hemovigilance Module 500 12 2/60
Monthly Reporting Plan.
Hemovigilance Module 500 12 2
Blood Product Incident
Reporting--Summary Data.
Hemovigilance Module 500 12 30/60
Monthly Reporting
Denominators.
Hemovigilance Incident.. 500 72 10/60
Hemovigilance Adverse 500 120 10/60
Reaction.
----------------------------------------------------------------------------------------------------------------
Dated: July 13, 2009.
Marilyn S. Radke,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. E9-17263 Filed 7-20-09; 8:45 am]
BILLING CODE 4163-18-P
